Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

OP-1 effective in preclinical model of stroke

Oct. 31, 1997

No Comments

Univ. Pennsylvania/Sparta issued seventh U.S. patent covering protease inhibitors

Oct. 30, 1997

No Comments

Profile of a peptide antidepressant: INN-00835

Oct. 30, 1997

No Comments

Vertex's neurophilin program makes progress

Oct. 30, 1997

No Comments

Novel targets for selectively interfering with chronic or neuropathic pain

Oct. 30, 1997

No Comments

AIT-082 shows promise for spinal cord injury

Oct. 30, 1997

No Comments

MS&D develops nonpeptide tachykinin antagonists

Oct. 30, 1997

No Comments

Effexor XR cleared by FDA

Oct. 28, 1997

No Comments

U.S. patent allowed for Hyal's lead product formulations

Oct. 28, 1997

No Comments

Janssen, Gliatech extend Alzheimer's disease research agreement

Oct. 27, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

OP-1 effective in preclinical model of stroke

Univ. Pennsylvania/Sparta issued seventh U.S. patent covering protease inhibitors

Profile of a peptide antidepressant: INN-00835

Vertex's neurophilin program makes progress

Novel targets for selectively interfering with chronic or neuropathic pain

AIT-082 shows promise for spinal cord injury

MS&D develops nonpeptide tachykinin antagonists

Effexor XR cleared by FDA

U.S. patent allowed for Hyal's lead product formulations

Janssen, Gliatech extend Alzheimer's disease research agreement

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Neurology/psychiatric RSS

Neurology/psychiatric
RSS